Using immune cells to develop new active substances and improve the efficacy and safety of drugs

- EN - DE
Professor Dr. Nico Lachmann uses novel reactor vessels that can produce human im
Professor Dr. Nico Lachmann uses novel reactor vessels that can produce human immune cells on a scalable scale. Copyright: ’Marco Oliveira’.

MHH researcher Nico Lachmann receives 2.5 million euros for Fraunhofer-Attract group



Immune cells and immune cell preparations are playing an increasingly important role in modern medicine.Nico Lachmann, research group leader at the Clinic for Paediatric Pneumology, Allergology and Neonatology at Hannover Medical School (MHH) and researcher of the RESIST Cluster of Excellence, wants to use standardised immune cells to test the efficacy and safety of drugs. For this project, he is also building The Attract working group is based at the Fraunhofer Institute for Toxicology and Experimental Medicine ITEM.

Standardised production of mature immune cells

The demand for human immune cells is high and growing daily. ...

account creation

TO READ THIS ARTICLE, CREATE YOUR ACCOUNT

And extend your reading, free of charge and with no commitment.

Register


Login


Subscribe